Global Meningococcal Vaccines Market By Product Type (Multivalent Vaccines, Monovalent Vaccines, and Conjugate Vaccines), By Age Group (Children, Infants, Adolescents, and Adults), By Administration Route (Subcutaneous, Intramuscular, and Oral), By Distribution Channel (Hospitals, Clinics, and Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2034

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Regional Overview
  • 1.6. Competitive Landscape
  • 1.7. Taxonomy
• 2. Global Market Overview
  • 2.1. Global Market Insights and Industry Overview
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunities
    • 2.2.4. Key Meningococcal Vaccines Market Trends
  • 2.3. Regulatory Framework
  • 2.4. Opportunity Map Analysis
  • 2.5. Opportunity Orbits
  • 2.6. PESTLE Analysis
  • 2.7. PORTER’S Five Force Analysis
  • 2.8. Drivers & Restraints Impact Analysis
  • 2.9. Value Chain Analysis
    • 2.9.1. List of Raw Materials Suppliers
    • 2.9.2. List of Meningococcal Vaccines Manufacturers
    • 2.9.3. List of Dealer/Distributors
  • 2.10. Regional Market Share and BPS Analysis
  • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
• 3. Global Meningococcal Vaccines Market Analysis and Forecast, By Segment, 2020-2034
  • 3.1. Key Findings
  • 3.2. Global Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 3.3. Global Meningococcal Vaccines Market Attractiveness Analysis, By Product Type
    • 3.3.1. Multivalent Vaccines
      • 3.3.1.1. Insights
      • 3.3.1.2. Key Takeaways
    • 3.3.2. Monovalent Vaccines
      • 3.3.2.1. Insights
      • 3.3.2.2. Key Takeaways
    • 3.3.3. Conjugate Vaccines
      • 3.3.3.1. Insights
      • 3.3.3.2. Key Takeaways
  • 3.4. Global Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Age Group, 2020-2034
  • 3.5. Global Meningococcal Vaccines Market Attractiveness Analysis, By Age Group
    • 3.5.1. Children
      • 3.5.1.1. Insights
      • 3.5.1.2. Key Takeaways
    • 3.5.2. Infants
      • 3.5.2.1. Insights
      • 3.5.2.2. Key Takeaways
    • 3.5.3. Adolescents
      • 3.5.3.1. Insights
      • 3.5.3.2. Key Takeaways
    • 3.5.4. Adults
      • 3.5.4.1. Insights
      • 3.5.4.2. Key Takeaways
  • 3.6. Global Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Administration Route, 2020-2034
  • 3.7. Global Meningococcal Vaccines Market Attractiveness Analysis, By Administration Route
    • 3.7.1. Oral
      • 3.7.1.1. Insights
      • 3.7.1.2. Key Takeaways
    • 3.7.2. Subcutaneous
      • 3.7.2.1. Insights
      • 3.7.2.2. Key Takeaways
    • 3.7.3. Intramuscular
      • 3.7.3.1. Insights
      • 3.7.3.2. Key Takeaways
  • 3.8. Global Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 3.9. Global Meningococcal Vaccines Market Attractiveness Analysis, By Distribution Channel
    • 3.9.1. Hospitals
      • 3.9.1.1. Insights
      • 3.9.1.2. Key Takeaways
    • 3.9.2. Clinics
      • 3.9.2.1. Insights
      • 3.9.2.2. Key Takeaways
    • 3.9.3. Pharmacies
      • 3.9.3.1. Insights
      • 3.9.3.2. Key Takeaways
• 4. Global Meningococcal Vaccines Market Analysis and Forecast, By Region, 2020-2034
  • 4.1. Key Findings
  • 4.2. Global Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    • 4.2.1. North America
      • 4.2.1.1. Regional Insights
    • 4.2.2. Europe
      • • 4.2.2.1. Regional Insights
    • 4.2.3. Asia Pacific
      • 4.2.3.1. Regional Insights
    • 4.2.4. Latin America
      • 4.2.4.1. Regional Insights
    • 4.2.5. Middle East & Africa
      • 4.2.5.1. Regional Insights
  • 4.3. Global Meningococcal Vaccines Market Attractiveness Analysis, By Region
• 5. North America Meningococcal Vaccines Market Analysis and Forecast, 2020-2034
  • 5.1. Key Findings
  • 5.2. North America Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 5.3. North America Meningococcal Vaccines Market Attractiveness Analysis, By Product Type
  • 5.4. North America Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Age Group, 2020-2034
  • 5.5. North America Meningococcal Vaccines Market Attractiveness Analysis, By Age Group
  • 5.6. North America Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Administration Route, 2020-2034
  • 5.7. North America Meningococcal Vaccines Market Attractiveness Analysis, By Administration Route
  • 5.8. North America Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 5.9. North America Meningococcal Vaccines Market Attractiveness Analysis, By Distribution Channel
  • 5.10. North America Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 5.11. North America Meningococcal Vaccines Market Attractiveness Analysis, By Country
    • 5.11.1. The US
    • 5.11.2. Canada
• 6. Europe Meningococcal Vaccines Market Analysis and Forecast, 2020-2034
  • 6.1. Key Findings
  • 6.2. Europe Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 6.3. Europe Meningococcal Vaccines Market Attractiveness Analysis, By Product Type
  • 6.4. Europe Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Age Group, 2020-2034
  • 6.5. Europe Meningococcal Vaccines Market Attractiveness Analysis, By Age Group
  • 6.6. Europe Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Administration Route, 2020-2034
  • 6.7. Europe Meningococcal Vaccines Market Attractiveness Analysis, By Administration Route
  • 6.8. Europe Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 6.9. Europe Meningococcal Vaccines Market Attractiveness Analysis, By Distribution Channel
  • 6.10. Europe Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 6.11. Europe Meningococcal Vaccines Market Attractiveness Analysis, By Country
    • 6.11.1. Germany
    • 6.11.2. The UK
    • 6.11.3. France
    • 6.11.4. Spain
    • 6.11.5. Italy
    • 6.11.6. Russia
    • 6.11.7. Netherland
    • 6.11.8. Rest of Europe
• 7. Asia Pacific Meningococcal Vaccines Market Analysis and Forecast, 2020-2034
  • 7.1. Key Findings
  • 7.2. Asia Pacific Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 7.3. Asia Pacific Meningococcal Vaccines Market Attractiveness Analysis, By Product Type
  • 7.4. Asia Pacific Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Age Group, 2020-2034
  • 7.5. Asia Pacific Meningococcal Vaccines Market Attractiveness Analysis, By Age Group
  • 7.6. Asia Pacific Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Administration Route, 2020-2034
  • 7.7. Asia Pacific Meningococcal Vaccines Market Attractiveness Analysis, By Administration Route
  • 7.8. Asia Pacific Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 7.9. Asia Pacific Meningococcal Vaccines Market Attractiveness Analysis, By Distribution Channel
  • 7.10. Asia Pacific Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 7.11. Asia Pacific Meningococcal Vaccines Market Attractiveness Analysis, By Country
    • 7.11.1. China
    • 7.11.2. Japan
    • 7.11.3. South Korea
    • 7.11.4. India
    • 7.11.5. Australia
    • 7.11.6. New Zealand
    • 7.11.7. Singapore
    • 7.11.8. Thailand
    • 7.11.9. Vietnam
    • 7.11.10. Rest of Asia Pacific
• 8. Latin America Meningococcal Vaccines Market Analysis and Forecast, 2020-2034
  • 8.1. Key Findings
  • 8.2. Latin America Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 8.3. Latin America Meningococcal Vaccines Market Attractiveness Analysis, By Product Type
  • 8.4. Latin America Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Age Group, 2020-2034
  • 8.5. Latin America Meningococcal Vaccines Market Attractiveness Analysis, By Age Group
  • 8.6. Latin America Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Administration Route, 2020-2034
  • 8.7. Latin America Meningococcal Vaccines Market Attractiveness Analysis, By Administration Route
  • 8.8. Latin America Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 8.9. Latin America Meningococcal Vaccines Market Attractiveness Analysis, By Distribution Channel
  • 8.10. Latin America Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 8.11. Latin America Meningococcal Vaccines Market Attractiveness Analysis, By Country
    • 8.11.1. Brazil
    • 8.11.2. Mexico
    • 8.11.3. Rest of Latin America
• 9. Middle East & Africa Meningococcal Vaccines Market Analysis and Forecast, 2020-2034
  • 9.1. Key Findings
  • 9.2. Middle East & Africa Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 9.3. Middle East & Africa Meningococcal Vaccines Market Attractiveness Analysis, By Product Type
  • 9.4. Middle East & Africa Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Age Group, 2020-2034
  • 9.5. Middle East & Africa Meningococcal Vaccines Market Attractiveness Analysis, By Age Group
  • 9.6. Middle East & Africa Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Administration Route, 2020-2034
  • 9.7. Middle East & Africa Meningococcal Vaccines Market Attractiveness Analysis, By Administration Route
  • 9.8. Middle East & Africa Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 9.9. Middle East & Africa Meningococcal Vaccines Market Attractiveness Analysis, By Distribution Channel
  • 9.10. Middle East & Africa Meningococcal Vaccines Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 9.11. Middle East & Africa Meningococcal Vaccines Market Attractiveness Analysis, By Country
    • 9.11.1. South Africa
    • 9.11.2. Saudi Arabia
    • 9.11.3. UAE
    • 9.11.4. Rest of Middle East & Africa
• 10. Competitive Landscape & Company Profiles
  • 10.1. Market Competition Scenario Analysis, By Company
  • 10.1.1. Key Takeaways
  • 10.2. Overview of Major Market Players
  • 10.3. Competitor Landscape
  • 10.4. Strategic Mapping
  • 10.5. Company Life Cycle Analysis
  • 10.6. Company Market Share Analysis
  • 10.7. Company Profiles
    • 10.7.1. Valneva
      • 10.7.1.1. Company Details
      • 10.7.1.2. Business Overview
      • 10.7.1.3. Product Portfolio
      • 10.7.1.4. Financial Insights
      • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.1.6. SWOT Analysis
      • 10.7.1.7. Geographic Footprint
    • 10.7.2. Serum Institute of India
      • 10.7.2.1. Company Details
      • 10.7.2.2. Business Overview
      • 10.7.2.3. Product Portfolio
      • 10.7.2.4. Financial Insights
      • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.2.6. SWOT Analysis
      • 10.7.2.7. Geographic Footprint
    • 10.7.3. Sanofi
      • 10.7.3.1. Company Details
      • 10.7.3.2. Business Overview
      • 10.7.3.3. Product Portfolio
      • 10.7.3.4. Financial Insights
      • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.3.6. SWOT Analysis
      • 10.7.3.7. Geographic Footprint
    • 10.7.4. Pfizer
      • 10.7.4.1. Company Details
      • 10.7.4.2. Business Overview
      • 10.7.4.3. Product Portfolio
      • 10.7.4.4. Financial Insights
      • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.4.6. SWOT Analysis
      • 10.7.4.7. Geographic Footprint
    • 10.7.5. MassBiologics
      • 10.7.5.1. Company Details
      • 10.7.5.2. Business Overview
      • 10.7.5.3. Product Portfolio
      • 10.7.5.4. Financial Insights
      • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.5.6. SWOT Analysis
      • 10.7.5.7. Geographic Footprint
    • 10.7.6. Hikma Pharmaceuticals
      • 10.7.6.1. Company Details
      • 10.7.6.2. Business Overview
      • 10.7.6.3. Product Portfolio
      • 10.7.6.4. Financial Insights
      • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.6.6. SWOT Analysis
      • 10.7.6.7. Geographic Footprint
    • 10.7.7. GlaxoSmithKline
      • 10.7.7.1. Company Details
      • 10.7.7.2. Business Overview
      • 10.7.7.3. Product Portfolio
      • 10.7.7.4. Financial Insights
      • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.7.6. SWOT Analysis
      • 10.7.7.7. Geographic Footprint
    • 10.7.8. Baxter International
      • 10.7.8.1. Company Details
      • 10.7.8.2. Business Overview
      • 10.7.8.3. Product Portfolio
      • 10.7.8.4. Financial Insights
      • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.8.6. SWOT Analysis
      • 10.7.8.7. Geographic Footprint
    • 10.7.9. Astellas Pharma
      • 10.7.9.1. Company Details
      • 10.7.9.2. Business Overview
      • 10.7.9.3. Product Portfolio
      • 10.7.9.4. Financial Insights
      • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.9.6. SWOT Analysis
      • 10.7.9.7. Geographic Footprint
• 11. Methodology and Data Source
  • 11.1. Methodology/Research Approach
  • 11.2. Market Size Estimation
  • 11.3. Market Breakdown and Data Triangulation
  • 11.4. Data Source
  • 11.5. Secondary Sources
  • 11.6. Primary Sources
  • 11.7. Appendix
  • 11.8. Disclaimer

List of Tables

• Table 1. Global Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 2. Global Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 3. Global Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 4. Global Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 5. Global Meningococcal Vaccines Market Value (US$ Mn), By Region, 2020-2034
• Table 6. North America Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 7. North America Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 8. North America Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 9. North America Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 10. North America Meningococcal Vaccines Market Value (US$ Mn), By Country, 2020-2034
• Table 11. The US Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 12. The US Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 13. The US Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 14. The US Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 15. Canada Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 16. Canada Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 17. Canada Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 18. Canada Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 19. Europe Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 20. Europe Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 21. Europe Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 22. Europe Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 23. Europe Meningococcal Vaccines Market Value (US$ Mn), By Country, 2020-2034
• Table 24. Germany Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 25. Germany Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 26. Germany Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 27. Germany Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 28. The UK Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 29. The UK Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 30. The UK Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 31. The UK Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 32. France Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 33. France Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 34. France Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 35. France Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 36. Spain Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 37. Spain Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 38. Spain Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 39. Spain Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 40. Italy Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 41. Italy Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 42. Italy Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 43. Italy Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 44. Russia Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 45. Russia Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 46. Russia Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 47. Russia Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 48. Netherland Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 49. Netherland Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 50. Netherland Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 51. Netherland Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 52. Rest of Europe Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 53. Rest of Europe Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 54. Rest of Europe Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 55. Rest of Europe Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 56. Asia Pacific Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 57. Asia Pacific Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 58. Asia Pacific Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 59. Asia Pacific Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 60. Asia Pacific Meningococcal Vaccines Market Value (US$ Mn), By Country, 2020-2034
• Table 61. China Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 62. China Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 63. China Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 64. China Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 65. India Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 66. India Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 67. India Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 68. India Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 69. Japan Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 70. Japan Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 71. Japan Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 72. Japan Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 73. South Korea Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 74. South Korea Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 75. South Korea Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 76. South Korea Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 77. Australia Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 78. Australia Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 79. Australia Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 80. Australia Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 81. New Zealand Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 82. New Zealand Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 83. New Zealand Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 84. New Zealand Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 85. Singapore Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 86. Singapore Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 87. Singapore Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 88. Singapore Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 89. Thailand Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 90. Thailand Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 91. Thailand Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 92. Thailand Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 93. Vietnam Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 94. Vietnam Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 95. Vietnam Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 96. Vietnam Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 97. Rest of Asia Pacific Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 98. Rest of Asia Pacific Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 99. Rest of Asia Pacific Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 100. Rest of Asia Pacific Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 101. Latin America Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 102. Latin America Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 103. Latin America Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 104. Latin America Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 105. Latin America Meningococcal Vaccines Market Value (US$ Mn), By Country, 2020-2034
• Table 106. Brazil Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 107. Brazil Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 108. Brazil Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 109. Brazil Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 110. Mexico Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 111. Mexico Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 112. Mexico Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 113. Mexico Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 114. Rest of Latin America Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 115. Rest of Latin America Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 116. Rest of Latin America Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 117. Rest of Latin America Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 118. Middle East & Africa Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 119. Middle East & Africa Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 120. Middle East & Africa Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 121. Middle East & Africa Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 122. Middle East & Africa Meningococcal Vaccines Market Value (US$ Mn), By Country, 2020-2034
• Table 123. South Africa Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 124. South Africa Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 125. South Africa Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 126. South Africa Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 127. Saudi Arabia Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 128. Saudi Arabia Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 129. Saudi Arabia Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 130. Saudi Arabia Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 131. UAE Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 132. UAE Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 133. UAE Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 134. UAE Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 135. Rest of Middle East & Africa Meningococcal Vaccines Market Value (US$ Mn), By Product Type, 2020-2034
• Table 136. Rest of Middle East & Africa Meningococcal Vaccines Market Value (US$ Mn), By Age Group, 2020-2034
• Table 137. Rest of Middle East & Africa Meningococcal Vaccines Market Value (US$ Mn), By Administration Route, 2020-2034
• Table 138. Rest of Middle East & Africa Meningococcal Vaccines Market Value (US$ Mn), By Distribution Channel, 2020-2034

List of Figures

• Figure 1. Global Meningococcal Vaccines Market Snapshot: Market Value (US$ Mn), 2020-2034
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. Regional Market Share and BPS Analysis in Meningococcal Vaccines Market
• Figure 5. Global Meningococcal Vaccines Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 6. Global Meningococcal Vaccines Market Attractiveness Analysis, By Product Type
• Figure 7. Global Meningococcal Vaccines Market Analysis, By Age Group, 2020, 2024 and 2034
• Figure 8. Global Meningococcal Vaccines Market Attractiveness Analysis, By Age Group
• Figure 9. Global Meningococcal Vaccines Market Analysis, By Administration Route, 2020, 2024 and 2034
• Figure 10. Global Meningococcal Vaccines Market Attractiveness Analysis, By Administration Route
• Figure 11. Global Meningococcal Vaccines Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 12. Global Meningococcal Vaccines Market Attractiveness Analysis, By Distribution Channel
• Figure 13. Global Meningococcal Vaccines Market Analysis, By Region, 2020, 2024 and 2034
• Figure 14. Global Meningococcal Vaccines Market Attractiveness Analysis, By Region
• Figure 15. North America Meningococcal Vaccines Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 16. North America Meningococcal Vaccines Market Attractiveness Analysis, By Product Type
• Figure 17. North America Meningococcal Vaccines Market (US$ Mn), by Multivalent Vaccines, 2020-2034
• Figure 18. North America Meningococcal Vaccines Market (US$ Mn), by Monovalent Vaccines, 2020-2034
• Figure 19. North America Meningococcal Vaccines Market (US$ Mn), by Conjugate Vaccines, 2020-2034
• Figure 20. North America Meningococcal Vaccines Market Analysis, By Age Group, 2020, 2024 and 2034
• Figure 21. North America Meningococcal Vaccines Market Attractiveness Analysis, By Age Group
• Figure 22. North America Meningococcal Vaccines Market (US$ Mn), by Children, 2020-2034
• Figure 23. North America Meningococcal Vaccines Market (US$ Mn), by Infants, 2020-2034
• Figure 24. North America Meningococcal Vaccines Market (US$ Mn), by Adolescents, 2020-2034
• Figure 25. North America Meningococcal Vaccines Market (US$ Mn), by Adults, 2020-2034
• Figure 26. North America Meningococcal Vaccines Market Analysis, By Administration Route, 2020, 2024 and 2034
• Figure 27. North America Meningococcal Vaccines Market Attractiveness Analysis, By Administration Route
• Figure 28. North America Meningococcal Vaccines Market (US$ Mn), by Oral, 2020-2034
• Figure 29. North America Meningococcal Vaccines Market (US$ Mn), by Subcutaneous, 2020-2034
• Figure 30. North America Meningococcal Vaccines Market (US$ Mn), by Intramuscular, 2020-2034
• Figure 31. North America Meningococcal Vaccines Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 32. North America Meningococcal Vaccines Market Attractiveness Analysis, By Distribution Channel
• Figure 33. North America Meningococcal Vaccines Market (US$ Mn), by Hospitals, 2020-2034
• Figure 34. North America Meningococcal Vaccines Market (US$ Mn), by Clinics, 2020-2034
• Figure 35. North America Meningococcal Vaccines Market (US$ Mn), by Pharmacies, 2020-2034
• Figure 36. North America Meningococcal Vaccines Market Analysis, By Country, 2020, 2024 and 2034
• Figure 37. North America Meningococcal Vaccines Market Attractiveness Analysis, By Country
• Figure 38. Europe Meningococcal Vaccines Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 39. Europe Meningococcal Vaccines Market Attractiveness Analysis, By Product Type
• Figure 40. Europe Meningococcal Vaccines Market (US$ Mn), by Multivalent Vaccines, 2020-2034
• Figure 41. Europe Meningococcal Vaccines Market (US$ Mn), by Monovalent Vaccines, 2020-2034
• Figure 42. Europe Meningococcal Vaccines Market (US$ Mn), by Conjugate Vaccines, 2020-2034
• Figure 43. Europe Meningococcal Vaccines Market Analysis, By Age Group, 2020, 2024 and 2034
• Figure 44. Europe Meningococcal Vaccines Market Attractiveness Analysis, By Age Group
• Figure 45. Europe Meningococcal Vaccines Market (US$ Mn), by Children, 2020-2034
• Figure 46. Europe Meningococcal Vaccines Market (US$ Mn), by Infants, 2020-2034
• Figure 47. Europe Meningococcal Vaccines Market (US$ Mn), by Adolescents, 2020-2034
• Figure 48. Europe Meningococcal Vaccines Market (US$ Mn), by Adults, 2020-2034
• Figure 49. Europe Meningococcal Vaccines Market Analysis, By Administration Route, 2020, 2024 and 2034
• Figure 50. Europe Meningococcal Vaccines Market Attractiveness Analysis, By Administration Route
• Figure 51. Europe Meningococcal Vaccines Market (US$ Mn), by Oral, 2020-2034
• Figure 52. Europe Meningococcal Vaccines Market (US$ Mn), by Subcutaneous, 2020-2034
• Figure 53. Europe Meningococcal Vaccines Market (US$ Mn), by Intramuscular, 2020-2034
• Figure 54. Europe Meningococcal Vaccines Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 55. Europe Meningococcal Vaccines Market Attractiveness Analysis, By Distribution Channel
• Figure 56. Europe Meningococcal Vaccines Market (US$ Mn), by Hospitals, 2020-2034
• Figure 57. Europe Meningococcal Vaccines Market (US$ Mn), by Clinics, 2020-2034
• Figure 58. Europe Meningococcal Vaccines Market (US$ Mn), by Pharmacies, 2020-2034
• Figure 59. Europe Meningococcal Vaccines Market Analysis, By Country, 2020, 2024 and 2034
• Figure 60. Europe Meningococcal Vaccines Market Attractiveness Analysis, By Country
• Figure 61. Asia Pacific Meningococcal Vaccines Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 62. Asia Pacific Meningococcal Vaccines Market Attractiveness Analysis, By Product Type
• Figure 63. Asia Pacific Meningococcal Vaccines Market (US$ Mn), by Multivalent Vaccines, 2020-2034
• Figure 64. Asia Pacific Meningococcal Vaccines Market (US$ Mn), by Monovalent Vaccines, 2020-2034
• Figure 65. Asia Pacific Meningococcal Vaccines Market (US$ Mn), by Conjugate Vaccines, 2020-2034
• Figure 66. Asia Pacific Meningococcal Vaccines Market Analysis, By Age Group, 2020, 2024 and 2034
• Figure 67. Asia Pacific Meningococcal Vaccines Market Attractiveness Analysis, By Age Group
• Figure 68. Asia Pacific Meningococcal Vaccines Market (US$ Mn), by Children, 2020-2034
• Figure 69. Asia Pacific Meningococcal Vaccines Market (US$ Mn), by Infants, 2020-2034
• Figure 70. Asia Pacific Meningococcal Vaccines Market (US$ Mn), by Adolescents, 2020-2034
• Figure 71. Asia Pacific Meningococcal Vaccines Market (US$ Mn), by Adults, 2020-2034
• Figure 72. Asia Pacific Meningococcal Vaccines Market Analysis, By Administration Route, 2020, 2024 and 2034
• Figure 73. Asia Pacific Meningococcal Vaccines Market Attractiveness Analysis, By Administration Route
• Figure 74. Asia Pacific Meningococcal Vaccines Market (US$ Mn), by Oral, 2020-2034
• Figure 75. Asia Pacific Meningococcal Vaccines Market (US$ Mn), by Subcutaneous, 2020-2034
• Figure 76. Asia Pacific Meningococcal Vaccines Market (US$ Mn), by Intramuscular, 2020-2034
• Figure 77. Asia Pacific Meningococcal Vaccines Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 78. Asia Pacific Meningococcal Vaccines Market Attractiveness Analysis, By Distribution Channel
• Figure 79. Asia Pacific Meningococcal Vaccines Market (US$ Mn), by Hospitals, 2020-2034
• Figure 80. Asia Pacific Meningococcal Vaccines Market (US$ Mn), by Clinics, 2020-2034
• Figure 81. Asia Pacific Meningococcal Vaccines Market (US$ Mn), by Pharmacies, 2020-2034
• Figure 82. Asia Pacific Meningococcal Vaccines Market Analysis, By Country, 2020, 2024 and 2034
• Figure 83. Asia Pacific Meningococcal Vaccines Market Attractiveness Analysis, By Country
• Figure 84. Latin America Meningococcal Vaccines Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 85. Latin America Meningococcal Vaccines Market Attractiveness Analysis, By Product Type
• Figure 86. Latin America Meningococcal Vaccines Market (US$ Mn), by Multivalent Vaccines, 2020-2034
• Figure 87. Latin America Meningococcal Vaccines Market (US$ Mn), by Monovalent Vaccines, 2020-2034
• Figure 88. Latin America Meningococcal Vaccines Market (US$ Mn), by Conjugate Vaccines, 2020-2034
• Figure 89. Latin America Meningococcal Vaccines Market Analysis, By Age Group, 2020, 2024 and 2034
• Figure 90. Latin America Meningococcal Vaccines Market Attractiveness Analysis, By Age Group
• Figure 91. Latin America Meningococcal Vaccines Market (US$ Mn), by Children, 2020-2034
• Figure 92. Latin America Meningococcal Vaccines Market (US$ Mn), by Infants, 2020-2034
• Figure 93. Latin America Meningococcal Vaccines Market (US$ Mn), by Adolescents, 2020-2034
• Figure 94. Latin America Meningococcal Vaccines Market (US$ Mn), by Adults, 2020-2034
• Figure 95. Latin America Meningococcal Vaccines Market Analysis, By Administration Route, 2020, 2024 and 2034
• Figure 96. Latin America Meningococcal Vaccines Market Attractiveness Analysis, By Administration Route
• Figure 97. Latin America Meningococcal Vaccines Market (US$ Mn), by Oral, 2020-2034
• Figure 98. Latin America Meningococcal Vaccines Market (US$ Mn), by Subcutaneous, 2020-2034
• Figure 99. Latin America Meningococcal Vaccines Market (US$ Mn), by Intramuscular, 2020-2034
• Figure 100. Latin America Meningococcal Vaccines Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 101. Latin America Meningococcal Vaccines Market Attractiveness Analysis, By Distribution Channel
• Figure 102. Latin America Meningococcal Vaccines Market (US$ Mn), by Hospitals, 2020-2034
• Figure 103. Latin America Meningococcal Vaccines Market (US$ Mn), by Clinics, 2020-2034
• Figure 104. Latin America Meningococcal Vaccines Market (US$ Mn), by Pharmacies, 2020-2034
• Figure 105. Latin America Meningococcal Vaccines Market Analysis, By Country, 2020, 2024 and 2034
• Figure 106. Latin America Meningococcal Vaccines Market Attractiveness Analysis, By Country
• Figure 107. Middle East & Africa Meningococcal Vaccines Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 108. Middle East & Africa Meningococcal Vaccines Market Attractiveness Analysis, By Product Type
• Figure 109. Middle East & Africa Meningococcal Vaccines Market (US$ Mn), by Multivalent Vaccines, 2020-2034
• Figure 110. Middle East & Africa Meningococcal Vaccines Market (US$ Mn), by Monovalent Vaccines, 2020-2034
• Figure 111. Middle East & Africa Meningococcal Vaccines Market (US$ Mn), by Conjugate Vaccines, 2020-2034
• Figure 112. Middle East & Africa Meningococcal Vaccines Market Analysis, By Age Group, 2020, 2024 and 2034
• Figure 113. Middle East & Africa Meningococcal Vaccines Market Attractiveness Analysis, By Age Group
• Figure 114. Middle East & Africa Meningococcal Vaccines Market (US$ Mn), by Children, 2020-2034
• Figure 115. Middle East & Africa Meningococcal Vaccines Market (US$ Mn), by Infants, 2020-2034
• Figure 116. Middle East & Africa Meningococcal Vaccines Market (US$ Mn), by Adolescents, 2020-2034
• Figure 117. Middle East & Africa Meningococcal Vaccines Market (US$ Mn), by Adults, 2020-2034
• Figure 118. Middle East & Africa Meningococcal Vaccines Market Analysis, By Administration Route, 2020, 2024 and 2034
• Figure 119. Middle East & Africa Meningococcal Vaccines Market Attractiveness Analysis, By Administration Route
• Figure 120. Middle East & Africa Meningococcal Vaccines Market (US$ Mn), by Oral, 2020-2034
• Figure 121. Middle East & Africa Meningococcal Vaccines Market (US$ Mn), by Subcutaneous, 2020-2034
• Figure 122. Middle East & Africa Meningococcal Vaccines Market (US$ Mn), by Intramuscular, 2020-2034
• Figure 123. Middle East & Africa Meningococcal Vaccines Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 124. Middle East & Africa Meningococcal Vaccines Market Attractiveness Analysis, By Distribution Channel
• Figure 125. Middle East & Africa Meningococcal Vaccines Market (US$ Mn), by Hospitals, 2020-2034
• Figure 126. Middle East & Africa Meningococcal Vaccines Market (US$ Mn), by Clinics, 2020-2034
• Figure 127. Middle East & Africa Meningococcal Vaccines Market (US$ Mn), by Pharmacies, 2020-2034
• Figure 128. Middle East & Africa Meningococcal Vaccines Market Analysis, By Country, 2020, 2024 and 2034
• Figure 129. Middle East & Africa Meningococcal Vaccines Market Attractiveness Analysis, By Country